These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17217317)
21. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642 [TBL] [Abstract][Full Text] [Related]
22. A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders. Schimmelmann BG; Mehler-Wex C; Lambert M; Schulze-zur-Wiesch C; Koch E; Flechtner HH; Gierow B; Maier J; Meyer E; Schulte-Markwort M J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):768-78. PubMed ID: 18315449 [TBL] [Abstract][Full Text] [Related]
23. Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. McIntyre A; Paisley D; Kouassi E; Gendron A Arthritis Rheumatol; 2014 Feb; 66(2):451-61. PubMed ID: 24504819 [TBL] [Abstract][Full Text] [Related]
24. [Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study]. Neves Ramos D; van West D; van Strien AP Tijdschr Psychiatr; 2007; 49(4):263-7. PubMed ID: 17436213 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea. Kim BN; Lee CB; Hwang JW; Shin MS; Cho SC J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. McCracken JT; Suddath R; Chang S; Thakur S; Piacentini J J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):501-8. PubMed ID: 18928414 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis. Liu Y; Ni H; Wang C; Li L; Cheng Z; Weng Z J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):436-41. PubMed ID: 26914764 [TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. Corson AH; Barkenbus JE; Posey DJ; Stigler KA; McDougle CJ J Clin Psychiatry; 2004 Nov; 65(11):1531-6. PubMed ID: 15554768 [TBL] [Abstract][Full Text] [Related]
29. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Gilbert DL; Sethuraman G; Sine L; Peters S; Sallee FR Neurology; 2000 Mar; 54(6):1310-5. PubMed ID: 10746603 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]
31. Quetiapine treatment in patients with Tourette syndrome. Párraga HC; Párraga MI Can J Psychiatry; 2001 Mar; 46(2):184-5. PubMed ID: 11280092 [No Abstract] [Full Text] [Related]
32. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H; J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490 [TBL] [Abstract][Full Text] [Related]
33. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128 [TBL] [Abstract][Full Text] [Related]
34. A Phase-2 Pilot Study of a Therapeutic Combination of Δ Bloch MH; Landeros-Weisenberger A; Johnson JA; Leckman JF J Neuropsychiatry Clin Neurosci; 2021; 33(4):328-336. PubMed ID: 34340527 [TBL] [Abstract][Full Text] [Related]
35. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Buckley PF Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome: A randomized controlled trial. Chen CW; Wang HS; Chang HJ; Hsueh CW J Adv Nurs; 2020 Mar; 76(3):903-915. PubMed ID: 31782167 [TBL] [Abstract][Full Text] [Related]
40. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia. Brecher M; Leong RW; Stening G; Osterling-Koskinen L; Jones AM J Clin Psychiatry; 2007 Apr; 68(4):597-603. PubMed ID: 17474816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]